Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Biochimica Et Biophysica Acta. Molecular Cell Research|January 29, 2020
GSK-3: An important kinase in colon and pancreatic cancersRoberto J Vidri, Timothy L Fitzgerald
World Journal of Surgery|April 23, 2021
Traveling to Receive Treatment for Extremity Soft Tissue Sarcomas: Is it worth the drive?Roberto J Vidri, Chandrajit P Raut, Timothy L Fitzgerald
Surgery|June 23, 2018
Tumor mitotic rate is an independent predictor of survival for nonmetastatic melanomaJessica L Evans, Roberto J Vidri, Dougald C MacGillivray, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 24, 2020
Upfront resection versus neoadjuvant therapy for T1/T2 pancreatic cancerRoberto J Vidri, William T Olsen, David E Clark, et al.
The American Surgeon|April 8, 2022
The Cost of Frailty in Complex Gastrointestinal SurgeryRoberto J Vidri, Abdimajid Mohamed, Joseph D Mack, et al.
Pediatric Surgery International|September 9, 2018
Can time to healing in pediatric blunt splenic injury be predicted?Catherine M Dickinson, Roberto J Vidri, Alexis D Smith, et al.
The Journal of Surgical Research|May 31, 2022
A Virtual Tumor Board Platform: A Way to Enhance Decision-Making for Complex MalignanciesSteven E Hopkins, Roberto J Vidri, Maureen V Hill, et al.
Annals of Surgical Oncology|July 10, 2019
Better Defining the Role of Total Neoadjuvant Radiation: Changing Paradigms in Locally Advanced Pancreatic CancerRoberto J Vidri, Anne O Vogt, Dougald C Macgillivray, et al.
Melanoma Research|March 7, 2022
Real-world frequency of BRAF testing and utilization of therapies in patients with advanced melanomaMaureen V Hill, Roberto J Vidri, Mengying Deng, et al.
Annals of Surgical Oncology|October 12, 2021
National Trends in Treatment for Retroperitoneal Soft Tissue Sarcoma: A Modern Appraisal of Variability in Therapeutic StrategiesAnthony M Villano, Roberto J Vidri, Elaine T Vo, et al.
Pageof 2